Antioxidant Fusion Protein SOD1-Tat Increases the Engraftment Efficiency of Total Bone Marrow Cells in Irradiated Mice

por Bei, Ting, Cao, Xusong, Liu, Yun, Li, Jinmei, Luo, Haihua, Huang, Lin, Tian, Tian, Li, Lei, Jiang, Yong
Publicado 2021

Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients

por Hua, Dingchao, Tian, Qiuhong, Wang, Xue, Bei, Ting, Cui, Lina, Zhang, Bei, Bao, Celimuge, Bai, Yuezong, Zhao, Xiaochen, Yuan, Peng
Publicado 2022

Tumor microenvironment features decipher the outperformance of neoadjuvant immunochemotherapy over chemotherapy in resectable non-small cell lung cancer

por Cai, Wenhan, Jing, Miao, Gu, Yajun, Bei, Ting, Zhao, Xiaochen, Chen, Shiqing, Wen, Jiaxin, Gao, Jie, Wu, Chongchong, Xue, Zhiqiang
Publicado 2022

Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study

por Cao, Guangming, Hua, Dingchao, Li, Jinfeng, Zhang, Xuefang, Zhang, Zhiqiang, Zhang, Bei, Bei, Ting, Cui, Lina, Chen, Shiqing, Wang, Shuzhen, Zhu, Lei
Publicado 2023

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer

por Chen, Yimeng, Wang, Xue, Du, Feng, Yue, Jian, Si, Yiran, Zhao, Xiaochen, Cui, Lina, Zhang, Bei, Bei, Ting, Xu, Binghe, Yuan, Peng
Publicado 2023

Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma

por Yan, Kai, Zhang, Ding, Chen, Yanan, Lu, Wenfeng, Huang, Mengli, Cai, Jinping, Chen, Shiqing, Bei, Ting, Bai, Yuezong, Lv, Jian, Fu, Yong, Zhang, Haibin
Publicado 2023

Landscape of RB1 alterations in 22,432 Chinese solid tumor patients

por Xu, Guanghui, Zheng, Jiyang, Wang, Shu, Wang, Yuhao, Li, Guixiang, Wang, Nan, She, Xueke, Duan, Weiming, Zhang, Hushan, Huang, Depei, Bei, Ting, Fu, Dan, Yang, Jianjun
Publicado 2022

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial

por Yang, Guozhen, Su, Xiaodong, Huang, Yuanheng, Luo, Guangyu, Wang, Zhiqiang, Cai, Peiqiang, Zheng, Yating, Bei, Ting, Huang, Mengli, Bai, Yuezong, He, Haoqiang, Xiang, Jin, Cai, Muyan, Zhong, Jiudi, Guo, Qiyu, Zhang, Xu
Publicado 2023

Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients

por Yue, Dongsheng, Liu, Weiran, Chen, Chen, Zhang, Tao, Ma, Yuchen, Cui, Longgang, Gu, Yajun, Bei, Ting, Zhao, Xiaochen, Zhang, Bei, Bai, Yuezong, Romero, Atocha, Xu-Welliver, Meng, Wang, Changli, Zhang, Zhenfa, Zhang, Bin
Publicado 2022

Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages

por Ding, Xionghui, Kambara, Hiroto, Guo, Rongxia, Kanneganti, Apurva, Acosta-Zaldívar, Maikel, Li, Jiajia, Liu, Fei, Bei, Ting, Qi, Wanjun, Xie, Xuemei, Han, Wenli, Liu, Ningning, Zhang, Cunling, Zhang, Xiaoyu, Yu, Hongbo, Zhao, Li, Ma, Fengxia, Köhler, Julia R., Luo, Hongbo R.
Publicado 2021

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial

por Song, Zhengbo, Li, Yuping, Chen, Shiqing, Ying, Shenpeng, Xu, Shuguang, Huang, Jianjin, Wu, Dan, Lv, Dongqing, Bei, Ting, Liu, Shuxun, Huang, Xiaoping, Xie, Congying, Wu, Xiaoyu, Fu, Jianfei, Hua, Feng, Wang, Wenxian, Xu, Chunwei, Gao, Chan, Cai, Shangli, Lu, Shun, Zhang, Yiping
Publicado 2022

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

por He, Wenwu, Leng, Xuefeng, Mao, Tianqin, Luo, Xi, Zhou, Lingxiao, Yan, Jiaxin, Peng, Lin, Fang, Qiang, Liu, Guangyuan, Wei, Xing, Wang, Kangning, Wang, Chenghao, Zhang, Sha, Zhang, Xudong, Shen, Xudong, Huang, Depei, Yi, Huan, Bei, Ting, She, Xueke, Xiao, Wenguang, Han, Yongtao
Publicado 2022

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

por Yang, Guozhen, Su, Xiaodong, Yang, Hong, Luo, Guangyu, Gao, Chan, Zheng, Yating, Xie, Wenzhuan, Huang, Mengli, Bei, Ting, Bai, Yuezong, Wang, Zhiqiang, Cai, Peiqiang, He, Haoqiang, Xiang, Jin, Cai, Muyan, Zhang, Yijun, Qu, Chunhua, Fu, Jianhua, Liu, Qianwen, Hu, Yi, Zhong, Jiudi, Huang, Yuanheng, Guo, Qiyu, Zhang, Xu
Publicado 2021